Aristeia Capital »

Bridgebio Pharma shares owned by Aristeia Capital

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Aristeia Capital from 13F filings

Historical chart of Aristeia Capital investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Aristeia Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Aristeia Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $25M 15M 1.68

More positions owned by Aristeia Capital

Invesco Qqq Trust Series 1 Unit Ser 1 Put Option (QQQ)
State Street Spdr S&p 500 Etf Trust Tr Unit Put Option (SPY)
SM Energy (SM)
Super Micro Computer Note 3.500% 3/0 (Principal)
Strategy Note 12/0 (Principal)
People Com New
Evergy Note 4.500%12/1 (Principal)
Heico Corp Cl A (HEI.A)
Akamai Technologies Note 0.250% 5/1 (Principal)
Guardant Health Debt 1.250% 2/1 (Principal)
Super Micro Computer 7 Dep Cm Sr A Wi
Doordash Note 5/1 (Principal)
Firstenergy Corp Note 3.625% 1/1 (Principal)
Super Micro Computer Note 2.250% 7/1 (Principal)
Strategy Note 3/0 (Principal)

View all positions for Aristeia Capital

Top funds holding Bridgebio Pharma

OZ Management
Camden Asset Management
Franklin Resources
Wolverine Asset Management
Ubs Global Asset Management Americas
Sunrise Partners Limited Partnership
Invesco
Citadel Advisors
BlackRock
Nuveen
Aristeia Capital
Alberta Investment Management Corporation
Jpmorgan Chase & Co
Ameriprise Financial
Bank of America Corporation

View all funds holding Bridgebio Pharma